Bioventure FZ LLC (“Bioventure”) and Al Razi Pharma Industries (“Al Razi”) sign an exclusive agreement for the commercialisation of an oncology product in the Kingdom of Saudi Arabia. Bioventure, a subsidiary of Yas Holding’s healthcare division GlobalOne Healthcare Holding (GHH), and Al Razi Pharma Industries, a Saudi national pharmaceutical company which is a subsidiary of